Position in PBYI
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,234,269
-$458,736 QoQ
Shares Held
349,651
-22.7% QoQ
Ownership
0.687%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GLOBEFLEX CAPITAL L P holds $38,255,818 across 17 Biotechnology names. PBYI ranks #4 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
260,706 | $11,181,680 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
450,580 | $11,156,360 | |
| 3 | RIGL |
Rigel Pharmaceuticals Inc
|
217,839 | $5,890,366 | |
| 4 | PBYI |
Puma Biotechnology, Inc.
This page
|
349,651 | $2,234,269 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
10,594 | $2,002,795 | |
| 6 | INCY |
Incyte Corp
|
15,643 | $1,472,319 | |
| 7 | MDXG |
Mimedx Group, Inc.
|
214,350 | $846,682 | |
| 8 | BDTX |
Black Diamond Therapeutics, Inc.
|
305,276 | $650,237 |
All Filings in PBYI
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,234,269 | 349,651 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,693,005 | 452,606 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $2,403,337 | 452,606 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,552,438 | 452,606 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,339,713 | 452,606 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,380,448 | 452,606 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,154,145 | 452,606 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,475,495 | 452,606 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,606,280 | 491,751 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,331,960 | 538,559 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,416,410 | 538,559 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,982,200 | 561,530 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,735,127 | 561,530 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,375,271 | 561,530 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,352,890 | 570,840 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,195,067 | 419,322 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,008,645 | 350,224 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,256,678 | 413,381 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $2,899,980 | 413,692 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,109,895 | 447,701 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $4,166,769 | 428,680 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $564,577 | 55,027 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $555,222 | 55,027 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $659,447 | 63,226 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||